Ikena Oncology, Inc. Recorded Big Gain
Mon, Aug 04, 2025 at 07:01 PM
Ikena Oncology, Inc. (IKNA:NASDAQ) shot up at $17.16, representing a gain of 1152.6%. On Mon, Aug 04, 2025, IKNA:NASDAQ hit a New 2-Week Intraday Low of $1.36. The stock got featured on our News Catalysts scanner on Fri, Jul 25, 2025 at 12:35 PM in the 'MERGER' category. From Mon, Jul 21, 2025, the stock recorded 20.00% Up Days and 81.82% Green Days
About Ikena Oncology, Inc. (IKNA:NASDAQ)
Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.
Top 10 Gainers:
- Ikena Oncology, Inc. (IKNA:NASDAQ), 1152.55%
- Verb Technology Company, Inc. (VERB:NASDAQ), 114.27%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 92.37%
- CommScope Holding Company, Inc. (COMM:NASDAQ), 86.26%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 85.4%
- Steelcase Inc. (SCS:NYSE), 62.87%
- Earlyworks Co., Ltd (ELWS:NASDAQ), 52.56%
- CASI Pharmaceuticals, Inc. (CASI:NASDAQ), 51.16%
- Lichen International Limited (LICN:NASDAQ), 48.03%
- ATA Creativity Global (AACG:NASDAQ), 36.11%